Biotech · Private company
Nordic Nanovector
Track this companyFree. Adds Nordic Nanovector to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- 10 MBq/kg BetalutinPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 100 mg/m2 lilotomabPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 15 MBq/kg BetalutinPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 20 MBq/kg BetalutinPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 40 mg lilotomabPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- 60 mg/m2 lilotomabPhase 2 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- BetalutinPhase 1 · Relapsed, Diffuse Large B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)PHASE1 · COMPLETED · started Mar 2, 2017ClinicalTrials.gov NCT02658968 · fetched Nov 12, 2026
- A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin LymphomaPHASE1_PHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01796171 · fetched Nov 12, 2026